✦ LIBER ✦
54 The epidermal growth factor receptor tyrosine kinase inhibitor, eriotinib (Tarceva TM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: interim results of a phase II trial
✍ Scribed by J. Patel; V. Miller; M. Kris; N. Shah; L. Tyson; B. Pizzo; M. Zakowski; M. Cespon; R. Heelan; D. Johnson
- Book ID
- 118620231
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 168 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.